Cytokinetics (CYTK) Gains 6.17% on June 23

Equities Staff  |

Cytokinetics Inc (NASDAQ: CYTK) shares moved 6.17%, or $2.65 per share, as on 11:53:09 est today. Since opening at $43.23, 354,794 shares of Cytokinetics have exchanged hands and the stock has moved between $46.20 and $43.23.  

This year the company has a YTD change of 5.73%.

Cytokinetics anticipates its next earnings on 2022-08-04.

For technical charts, analysis, and more on Cytokinetics visit the company profile.

About Cytokinetics Inc

Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.

To get more information on Cytokinetics Inc and to follow the company's latest updates, you can visit the company's profile page here: Cytokinetics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade

Market Movers

Sponsored Financial Content